Edward Bradley Pewitt, MD
Urology · Gahanna, OHNPI 1104873744
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $608, more than ten times the $27 reported in 2019. That places this record below the midpoint for urology clinicians in OH, where the typical reported total is $2,547.
Across 111 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$427
- Sumitomo Pharma America, Inc.$270
- Myriad Genetic Laboratories, Inc.$191
- Sanofi$152
- Urogen Pharma, Inc.$146
- Conmed Corporation$143
- plus $710 from 17 others
Across 2 payments — averaging $52,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Conmed Corporation$105K
What the payments were for
- Food & beverage$2,040100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 47 | $427 |
| Sumitomo Pharma America, Inc. | 13 | $270 |
| Myriad Genetic Laboratories, Inc. | 5 | $191 |
| Sanofi | 2 | $152 |
| Urogen Pharma, Inc. | 7 | $146 |
| Conmed Corporation | 1 | $143 |
| Astellas Pharma US Inc | 6 | $104 |
| Pfizer | 5 | $95 |
| AbbVie | 3 | $66 |
| Myovant Sciences Inc. | 3 | $63 |
| Progenics Pharmaceuticals, Inc. | 2 | $62 |
| Urovant Sciences Inc | 3 | $60 |
| Tolmar, Inc. | 2 | $39 |
| Laborie Medical Technologies Corp. | 2 | $34 |
| Merck | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Mission Pharmacal Company | 1 | $26 |
| Telix Pharmaceuticals | 1 | $23 |
| Immunitybio, Inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Accord Healthcare, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,040 in reported general payments places this provider in the 45th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 654 | $21,067 |
| Finasteride | 524 | $9,474 |
| Potassium Citrate ErPotassium Citrate | 48 | $7,155 |
| Solifenacin Succinate | 75 | $4,139 |
| Potassium Chloride | 42 | $1,857 |
| Chlorthalidone | 80 | $1,431 |
| Methenamine Hippurate | 20 | $1,280 |
| Estradiol | 21 | $1,269 |
| Oxybutynin Chloride ErOxybutynin Chloride | 45 | $1,046 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 55 | $971 |
| Dutasteride | 14 | $774 |
| Oxybutynin Chloride | 24 | $427 |
| Terazosin Hcl | 15 | $392 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 39 | $340 |
| Allopurinol | 16 | $246 |
Paid to pharmacies, not to this prescriber.
Other urology in Gahanna
- Benjamin MartinGahanna$205K
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Ruben OlivaresCleveland$184K
- Abhinav SidanaCincinnati$174K
- Raymond RackleyCleveland$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.